The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB),
including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB
correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system.
Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly
prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
New submissions guidance has been posted!
-
It’s HERE @Manufacturer and @Agency !
The NEW Guidance on Submission Process and Format Requirements housing a complete outline of the submission procedures and practices to take effect July 4th.
You’ll see a full breakdown of submission requirements across ARO and the standard pathway for reviews. While you’ll recognize some requirements, PAAB has elaborated on submission features that will help facilitate an efficient and timely review across all pieces.
Head over to the PAAB website and check it out today.
